November 1, 2022 01:37 PM EDTUpdated November 17, 06:46 AM
Pharma
Manufacturing

#CPHI22: As Sam­sung’s new plant comes on­line, it looks to ex­pand in Ko­rea and be­yond

Tyler Patchen

News Reporter

FRANK­FURT, Ger­many — It is no se­cret that the CD­MO arm of one of South Ko­rea’s largest con­glom­er­ates has been ex­pand­ing in 2022. In the mid­dle …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

RFK Jr. and Elon Musk want to ban phar­ma ads. They would­n't be the first to try

Jazz wins ap­proval for bis­pe­cif­ic in bil­iary tract can­cer

No­var­tis seeks more bolt-on deals as it pur­chas­es neu­ro start­up for up to $1.1B

At Jef­feries, all that man­u­fac­tur­ers want to talk about is GLP-1s

FDA ad­comm rais­es risk ques­tions on As­traZeneca’s An­dexxa

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times